Stage I NSCLC patients who receive radiation therapy are surviving longer

Stage I, non-small cell lung cancer patients who received radiation therapy have an increased median survival of 21 months compared to 16 months, and the percentage of patients who receive no treatment declined from 20 percent to 16 percent, respectively, when comparing the two eras evaluated, 1999-2003 and 2004-2008, according to detailed analysis of the SEER-17 national database presented at the 2012 Chicago Multidisciplinary Symposium in Thoracic Oncology.

Read the whole article on Science Daily

More from Science Daily